Takeda Pharmaceutical Co. Ltd. reported its financial results for the nine-month period ending December 31, 2023, showing revenue of JPY 3,212.9 billion (up 4.6% year-on-year), while net profit significantly declined by 48.5% to JPY 147.2 billion. The company's performance was affected by a drop in oncology revenues and increased competition in some segments.